The FOXG1 Research Foundation (FRF) is a 501(c)(3) not-for-profit, global organization driving the research to find a cure for FOXG1 syndrome and related brain disorders. Established in 2017, the FOXG1 Research Foundation is driven by a clear, strategic path to a cure guided by a prestigious Scientific Advisory Board composed of leading neurologists, geneticists, clinicians, scientists, and biopharma executives. The FRF is centered on developing and funding the most proficient scientific strategy while advocating for FOXG1 families worldwide and being an active collaborator in the rare disease community. The FRF is also a Chan Zuckerberg Initiative "Rare As One" partner and a Rarebase collaborator. FOXG1 syndrome is a rare neurological gestational disorder that affects nearly 1,000 children worldwide. FOXG1 characteristics include epilepsy and severe physical and cognitive disabilities. The FOXG1 gene is linked to other brain disorders affecting millions including autism, schizophrenia, Alzheimer's, brain cancers, and more.